Results 31 to 40 of about 41,154 (301)

History of Psychopharmacology

, 2010
The field of psychopharmacology may be regarded as the point of confluence of theories, lines of inquiry, and methodologies pertaining to pharmacology, psychology, and psychiatry.
BADIANI, Aldo
core   +1 more source

Effects of Antidepressants [PDF]

, 2012
Over the last fifty years, many studies of psychiatric medication have been carried out on the basis of psychopharmacology. At the beginning, researchers and clinicians found the unexpected effectiveness of some medications with therapeutic effects in ...

core   +2 more sources

The role of harms and burdens in clinical practice guidelines: Lessons learned from the American Psychological Association's guideline development

Clinical Psychology: Science and Practice, EarlyView., 2020
Abstract Growing evidence supports the efficacy of various psychosocial interventions yet provides very little information about the potential harms and burdens of treatment. Lacking such information makes it difficult to make truly informed decisions about treatment options.
Raquel W. Halfond, Caroline Vaile Wright, Lynn F. Bufka   +2 more
wiley   +1 more source

Decreasing Nicotine Content Reduces Subjective and Physiological Effects of Smoking

Tobacco Use Insights, 2012
Objective Assessment of the subjective and physiological effects of smoking cigarettes with different machine-smoked nicotine yields. Methods Eight volunteers rated the characteristics of cigarettes with varying levels of nicotine (Quest ® ).
David M. Penetar, Kimberly P. Lindsey, Erica N. Peters, Trisha M. Juliano, Scott E. Lukas   +4 more
doaj   +1 more source

Findings from a pilot open-label trial of N-acetylcysteine for the treatment of pediatric mania and hypomania

BMC Psychiatry, 2022
Background Pediatric bipolar disorder is a highly prevalent and morbid disorder and is considered a prevalent public health concern. Currently approved treatments often pose the risk of serious side effects.
Janet Wozniak, Maura DiSalvo, Abigail Farrell, Carrie Vaudreuil, Mai Uchida, T. Atilla Ceranoglu, Gagan Joshi, Emmaline Cook, Stephen V. Faraone, Joseph Biederman   +9 more
doaj   +1 more source

Effect of oxycodone vs. morphine as first‐line opioid on new persistent opioid use after orthopaedic surgery: A prospective sequential cohort study

British Journal of Clinical Pharmacology, EarlyView.
Abstract Background Postoperative opioids, intended for short‐term analgesia, contribute to new persistent opioid use in 1%–7% of patients, adversely affecting outcomes. Oxycodone may carry higher risk than morphine, though long‐term data are limited.
Eward J. Melis, Johanna E. Vriezekolk, Frédérique H. C. Bollen, Dirk E. Schrander, Arnt F. A. Schellekens, Bart J. F. van den Bemt   +5 more
wiley   +1 more source

Online cognitive training in healthy older adults: a preliminary study on the effects of single versus multi-domain training

Translational Neuroscience, 2015
It has been argued that cognitive training may be effective in improving cognitive performance in healthy older adults. However, inappropriate active control groups often hinder the validity of these claims.
Walton Courtney C, Kavanagh Alexandra, Downey Luke A., Lomas Justine, Camfield David A, Stough Con   +5 more
doaj   +1 more source

Ethno-psychopharmacology [PDF]

International Psychiatry, 2007
How we judge in what way, with what potential side-effects, our patients respond to medications designed to help them recover from their psychiatric disorders is informed by experience, scientific knowledge and guesswork. The rapid movement of populations around the world, usually voluntary but sometimes driven by other motives or exigencies, means ...
openaire   +2 more sources

Exploring new avenues: Psychedelic‐assisted therapy for young people

British Journal of Clinical Pharmacology, EarlyView.
Rates of mental illness in young people are increasing, whereas the development of novel mental health treatments has not significantly progressed. Psychedelic‐assisted therapy, using substances such as psilocybin and 3,4‐methylenedioxymethamphetamine (MDMA), has shown potential in the treatment of mental illnesses in the adult population, including ...
Ioanna Artemis Vamvakopoulou, Dasha Nicholls, David J. Nutt, Martina Di Simplicio   +3 more
wiley   +1 more source

The Serotonin 2B (5‐HT2B) Receptor: A Narrative Review of Preclinical and Clinical Evidence on the Safety Considerations and Therapeutic Potential for the Treatment of Depression

Clinical Pharmacology &Therapeutics, EarlyView.
Major depressive disorder (MDD) and treatment‐resistant depression (TRD) remain leading causes of disability, providing the impetus for receptor‐level treatment strategies beyond monoamine reuptake. The serotonin 5‐HT2B receptor (5‐HT2BR) is uniquely positioned at the interface of central‐antidepressant mechanisms and peripheral cardiac risks.
Gia Han Le, Sabrina Wong, Danica E. Johnson, Diana K. Orsini, Yang Jing Zheng, Kayla M. Teopiz, Christine E. Dri, Joshua D. Rosenblat, Roger S. McIntyre   +8 more
wiley   +1 more source